Chronic Low Back Pain (CLBP) Treatment Market Growth Driven by Rising Prevalence of Musculoskeletal Disorders
Chronic low back pain (CLBP) treatment market is driven by the increasing prevalence of musculoskeletal disorders, sedentary lifestyles, and rising geriatric population globally. The demand for analgesic medications, nonsteroidal anti-inflammatory drugs (NSAIDs), anticonvulsants, and antidepressants is growing as primary treatment options for pain management and symptom relief. Additionally, expanding healthcare infrastructure, increasing awareness regarding early diagnosis and treatment, and growing adoption of advanced therapeutic approaches across hospitals, orthopedic clinics, and ambulatory surgery centers are further supporting the growth of the global CLBP treatment market.
Browse the full report description of “Chronic Low Back Pain (CLBP) Treatment Market Size, Share & Trends Analysis Report by Treatment Type (Analgesic Medications, Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), Anticonvulsants, Antidepressants, and Others), by Distribution Channel (Online and Offline), and by End-User (Hospitals, Orthopedic Clinic, Ambulatory Surgery Centers, and Others) Forecast Period (2023-2030)” at https://www.omrglobal.com/industry-reports/chronic-low-back-pain-clbp-treatment-market
Boston Scientific WaveWriter Alpha spinal cord stimulation platform expansion is expected to strengthen chronic pain management adoption in 2025
Boston Scientific expanded its WaveWriter Alpha Spinal Cord Stimulator platform during 2024–2025, supporting wider clinical adoption for chronic low back pain and neuropathic pain management across global healthcare systems. The expansion is expected to strengthen the use of advanced neuromodulation therapies as a preferred treatment option for patients suffering from chronic pain conditions. Increasing prevalence of chronic low back pain, growing burden of neuropathic disorders, and rising demand for minimally invasive pain management solutions are key factors driving adoption of spinal cord stimulation technologies. Boston Scientific’s enhanced SCS platform is expected to improve patient outcomes, expand clinical utilization, and support broader integration of neuromodulation therapies in pain management practices.
Medtronic spinal cord stimulation systems expansion is expected to reinforce neuromodulation leadership in chronic pain treatment in 2025
Medtronic expanded global adoption of its Spinal Cord Stimulation (SCS) systems, including Intellis™ and Vanta™, during 2024–2025, strengthening its leadership in chronic low back pain (CLBP) neuromodulation treatment through increased clinical use across pain management centers. The expansion is expected to support growing demand for advanced implantable pain management technologies in global healthcare systems. Rising incidence of chronic pain conditions, increasing preference for non-opioid treatment alternatives, and advancements in neurostimulation technology are driving adoption of spinal cord stimulation therapies. Medtronic’s expanded SCS portfolio is expected to improve pain relief outcomes, enhance patient quality of life, and strengthen its position in the global neuromodulation market.
About OMR Global
OMR Global is a market intelligence and strategic consulting firm specializing in growth advisory, competitive intelligence, and AI-enabled business research across global B2B industries.
The company supports enterprises, investors, and technology providers with actionable insights for market entry, investment analysis, procurement strategy, commercialization, and business expansion. OMR Global combines industry expertise, primary research, analytics, and digital intelligence tools to help organizations navigate evolving market landscapes and identify growth opportunities.
OMR Digital Offerings
- Pulse Intelligence Platform – AI-powered market intelligence suite designed to deliver analyst-grade insights faster and more efficiently. Built on 12+ years of research expertise and enhanced with AI-driven analytics, Pulse helps organizations transform large volumes of market and company data into actionable intelligence within hours instead of weeks. Trusted by Fortune 500 enterprises, global investment banks, strategy consultancies, and PE & VC firms, Pulse supports strategic decision-making across investment evaluation, competitive benchmarking, AI readiness, and market positioning.
Other Offerings
- Lead Generation – Verified B2B prospect data, ICP targeting, and intent-based sales intelligence
- RFx Support – End-to-end RFP, RFI, and RFQ support with vendor benchmarking and evaluation frameworks
OMR Global delivers data-driven intelligence solutions designed to support strategic decision-making, operational efficiency, and long-term business growth.
To find out more, visit www.omrglobal.com
Contact:
Mr. Anurag Tiwari
305-308, Commerce House, Janjeerwala Square,
Indore, Madhya Pradesh 452001
India
+91-780-304-0404